Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Recruiting

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

NCT04988555

Conditions
Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +25 more
Locations
  • Hoag Family Cancer Center Newport Beach, California, United States
  • Stanford University Palo Alto, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Georgetown Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States
View all 104 locations
View Trial Details
Recruiting

MZL-IPI Risk-adapted Targeted Therapy in Untreated MZL

NCT06793189

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Shanghai Ruijin Hospital Shanghai, China
  • Affiliated First Hospital of China Medical University Shenyang, Liaoning, China
  • Peking University Third Hospital Beijing, China
View Trial Details

Related conditions